Elevate the standard of care
Explore novel applications
Advance our understanding of cardiovascular disease and improve our ability to prevent and treat it
Strong foothold in Research
VICORDER® plays a pivotal role across various medical research domains, facilitating the exploration of cardiovascular effects.
It's utilization spans a diverse range of specialties including epidemiology, cardiology, gynecology, nephrology, diabetology, pediatrics, and sports medicine. This instrument has underpinned a multitude of studies and scholarly articles, providing insights into cardiovascular health and disease. Application in these fields underscores the instrument's versatility and critical contribution to medical science.
Visit Vascular-Diagnostics.com
For more cardiovascular testing methods in the fields of Arterial Stiffness, Long Covid, Endothelial Function and Pediatrics
Endothelial Function Testing with Flow Mediated Slowing (FMS)
A new parameter to understand cardiovascular risk
Innovative health solutions, particularly in health care, the evaluation of endothelial function stands as a crucial component for cardiovascular risk assessment. Traditional methodologies, such as flow mediated dilation (FMD), though widely recognized, demand substantial technical expertise and can be clinically demanding. Our pioneering approach introduces a simpler and more efficient technique known as flow mediated slowing (FMS), which seamlessly assimilates into clinical workflows.
This non-invasive method significantly reduces the necessary time, skill, and financial investment typically required for effective endothelial testing, thereby enhancing the practicality and accessibility of cardiovascular monitoring and management.
Pulse Amplitude Ratio (PAR)
Most advanced test determining peripheral arterial vasomotor function
Assessing the cardiovascular risk in individuals often entails evaluating endothelial function as an important biomarker. Flow mediated dilation (FMD) and flow mediated slowing are commonly utilized to gauge the reactivity of larger blood vessels, while other methodologies focus on the smaller vascular structures. These tests are particularly useful in large-scale epidemiological studies and when characterizing the cardiovascular phenotype in the general population.
Such assessments are integral components of comprehensive cardiovascular risk assessment strategies, offering insights into vascular health and potential early indicators of cardiovascular diseases.
Central Blood Pressure (cBP) and Pulse Wave Analysis (PWA)
Maintaining cardiovascular health is paramount in reducing the risk factors for cardiovascular disease. Central blood pressure is a vital sign of the heart and vascular system's health, serving as an imperative metric in cardiovascular research. Through the implementation of pulse wave analysis, scientists and clinicians can evaluate the impact of various therapeutic strategies on cardiovascular function.
This technique is instrumental in the development of targeted interventions to bolster heart health. Continued investigation into pulse wave analysis enhances the knowledge base surrounding cardiovascular pathology, fostering improvements in preventative and remedial care.
Pulse Wave Velocity (PWV)
A measurement of arterial stiffness that is an independent predictor of cardiovascular risk
Pulse wave velocity measurement serves as a cornerstone in the evaluation of arterial stiffness, a crucial indicator of cardiovascular health. This non-invasive technique provides significant data for cardiovascular risk assessment, allowing health care professionals to identify and monitor risk factors for cardiovascular disease.
Innovative health solutions now incorporate pulse wave velocity as a standard metric to gauge the efficacy of interventions aimed at improving cardiovascular outcomes. By tracking changes in pulse wave velocity, medical experts can better understand the impact of different variables on the arterial system and thus refine strategies for disease prevention and management.